1-3 of 3
Martina Ulrike Muckenthaler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Favorable Effect of Activating NOTCH1 Receptor Mutations On Long Term Outcome in T-ALL Is Treatment Related and Can Be Separated From NOTCH Pathway Activation by FBXW7 Loss of Function.

Corinne Kox, Martin Zimmermann, PhD, Martin Stanulla, MD, Martin Schrappe, MD, Wolf-Dieter Ludwig, Rolf Koehler, PhD, Svenja Leible, Gabriele Tolle, Obul Reddy Bandapalli, Stephen Breit, Martina Ulrike Muckenthaler, Andreas Kulozik, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 908.
https://doi.org/10.1182/blood.V114.22.908.908
Published: 2009
Journal Articles

High-Resolution Genomic Profiling (array-CGH) of Childhood T-ALL Identifies Deletions at 6q15-16.1 as a Predictive Marker for Early Treatment Response.

Marc Remke, Stefan Pfister, Martin Stanulla, Martin Schrappe, Martina Ulrike Muckenthaler, Peter Lichter, Andreas Kulozik
Journal: Blood
Blood (2008) 112 (11): 1484.
https://doi.org/10.1182/blood.V112.11.1484.1484
Published: 2008
Journal Articles

Notch Pathway Activation by a Combination of Activating NOTCH1 -Receptor and Inactivating FBXW7 Mutations Robustly Predicts Excellent Early Treatment Response in Pediatric T-ALL.

Corinne Kox, Svenja Leible, Stephen Breit, Martin Stanulla, MD, Martin Schrappe, MD, Martina Ulrike Muckenthaler, Andreas Kulozik
Journal: Blood
Blood (2008) 112 (11): 1493.
https://doi.org/10.1182/blood.V112.11.1493.1493
Published: 2008